Ob/Gyn and Women's Health Perspective

• Key Updates in Early Breast Cancer From SABCS 2024   Key updates from SABCS 2024 in early breast cancer include the COMET study on DCIS recurrence, INSEMA trial on SLNB omission, and OlympiA updates on adjuvant olaparib, shared by Dr Harold Burstein.
  Medscape, January 09, 2025
• The Year’s Notable Guidelines: Highlights for Primary Care   Dr Neil Skolnik reviews key guidelines from 2024 that should not be missed by primary care clinicians.
  Medscape Family Medicine, January 08, 2025
• Can GLP-1s Reduce Alzheimer’s Disease Risk? Caroline Messer, MD, shares how she prescribed a GLP-1 receptor agonist to a patient as possible low-risk prophylaxis against Alzheimer’s disease.
  Medscape Diabetes & Endocrinology, January 08, 2025
• Making Sense of Mixed Messages on Drinking   Medscape’s Neha Pathak, MD, and George Koob, PhD, Director of the National Institute on Alcohol Abuse and Alcoholism, break down the latest guidance on alcohol intake.
  Medscape Family Medicine, January 07, 2025
• The Year’s Hottest Topics in Pediatric Medicine As we head into 2025, Dr William Basco comments on 2024’s most important news for pediatric clinicians.
  Medscape Pediatrics, January 07, 2025
• History Repeats? Lead Pollution and the Roman Economy   A story hidden in the icy layers of the Arctic may have lessons for cognitive health in the modern era.
  Medscape, January 07, 2025
• Three-Year Medical School Can Work: Ethicist   Ethicist Art Caplan discusses the benefits of a 3-year medical school curriculum.
  Medscape Business of Medicine, January 03, 2025
• Conference MDAngle: SABCS 2024 Hormone Receptor (HR)–Positive, HER2-Negative Breast Cancer Drs Armaghani and Henry share SABCS 2024 highlights, including anticipated presentations, quick takeaways, and insights into how new research will affect their patients.
  Medscape, January 02, 2025
• Updates in ER-Positive Breast Cancer From SABCS 2024   Updates in ER+ breast cancer from SABCS 2024 include the EMBER-3 trial of novel oral SERD imlunestrant, PATINA trial results, and updated analysis from TAILORx, as reported by Dr Harold Burstein.
  Medscape, January 02, 2025
• SABCS 2024: Clinical Impact of Advances in HR+ Breast Cancer   Drs Armaghani and Henry share SABCS 2024 highlights, including anticipated presentations, quick takeaways, and insights into how new research will affect their patients.
  Medscape, January 02, 2025
• Medscape 2050: The Future of Medicine As Medscape marks its 30th anniversary, we are collaborating with physicians, scientists, and futurists to envision the future of medicine in the year 2050.
  Medscape, January 01, 2025
• ASH 2024: Improving Care in Red Blood Cell Disorders   Dr Nadia Ali shares ASH 2024 highlights, including anticipated presentations, quick takeaways, and insights into the impact of new research in red blood cell disorders.
  Medscape, December 31, 2024
• SABCS 2024: Insights on New Data in HR+/HER2- Breast Cancer   Dr Armaghani highlights breakthroughs from the 2024 San Antonio Breast Cancer Symposium, including new therapies for high-risk breast cancer.
  Medscape, December 20, 2024
• “I Had No Words”: The Patient Gifts Doctors Never Forget   These doctors were surprised and moved by very personal gifts given to them by grateful patients. Enjoy some good vibes this holiday season.
  Medscape, December 19, 2024
• Episode 6: HER2-Ultra-Low Breast Cancer   Drs Kathy Miller and Francisco J. Esteva discuss testing and therapeutic options for the new classification of HER2-ultra-low breast cancer.
  Medscape, December 19, 2024
• SABCS 2024: Key Highlights in HR+/HER2- Breast Cancer   Dr Norah Henry shares insights on treatment advances in first- and second-line settings, including the PADMA, EMBER-3, and DESTINY-Breast06 trials.
  Medscape, December 19, 2024
• The Reason Taxi Drivers Are Protected From Alzheimer’s   And for the rest of us, what can we learn from the unique skill of a cabbie that confers this benefit? Dr F Perry Wilson reveals the secret in this week’s Impact Factor.
  Medscape, December 17, 2024
• Injectable Weight Loss Drugs and Environmental Issues   Ethicist Art Caplan discusses ethical and environmental issues related to the use of injectable drugs for weight loss.
  Medscape Business of Medicine, December 16, 2024
• SABCS 2024 Studies to Watch: San Antonio Breast Cancer Symposium   Dr Kathy Miller discusses studies of interest at the upcoming San Antonio Breast Cancer Symposium.
  Medscape Oncology, December 16, 2024
• UTI in Primary Care: New Guidelines   The latest evidence-based recommendations for diagnosis, treatment, and prevention of recurrent UTI are reviewed here.
  Medscape Family Medicine, December 16, 2024